Clinical Trials Browser

Phase 2/3 × Biliary Tract Neoplasms × surufatinib × Clear all

NCT03873532 2020-02-13

A Trial Evaluating Surufatinib Efficacy and Safety in Biliary Tract Carcinoma Patients

Phase 2/3 Unknown

Gastrointestinal

Biliary Tract Neoplasms